Immunic (IMUX) Other Working Capital Changes (2013 - 2026)

Immunic has disclosed Other Working Capital Changes across 14 years of filings, most recently posting -$149000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$149000.0, down 156.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 274.23% YoY), and the FY2025 annual result was $3.2 million, up 267.6% from the prior year.
• Other Working Capital Changes came in at -$149000.0 for Q1 2026 at Immunic, down from $3.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $3.3 million in Q4 2025 to a low of -$5.4 million in Q4 2022.
• The 5-year median for Other Working Capital Changes is -$149000.0 (2026), against an average of -$601470.6.
• Across the five-year window, Other Working Capital Changes soared 652.93% in 2022 and tumbled 6678.26% in 2024, its largest moves.
• Immunic's Other Working Capital Changes stood at -$5.4 million in 2022, then surged by 100.42% to $23000.0 in 2023, then sank by 6678.26% to -$1.5 million in 2024, then jumped by 320.03% to $3.3 million in 2025, then slumped by 104.48% to -$149000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$149000.0 (Q1 2026), $3.3 million (Q4 2025), and -$50000.0 (Q3 2025), per Business Quant data.